Twinstrand duplex sequencing mutagenesis kit
Ended Purchase Order Awarded Last action
- Contract number
- 75F40124P00263
- Awardee
-
Twinstrand Biosciences Inc. UEI HPY9BJWV8X31
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $49,988
Award facts
- Contract value 100% obligated
- $49,987.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Seattle, WA 98121, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $49,988 |
About this award
The Food and Drug Administration (FDA) awarded a $49,987.65 firm fixed price purchase order to Twinstrand Biosciences Inc. on June 27, 2024, for the Twinstrand Duplex Sequencing Mutagenesis Kit. The contract, with performance in Seattle, Washington, has an ultimate completion date of September 25, 2024, and was not issued under any set-aside designation. Twinstrand Biosciences Inc., a specialized genomic research company registered in the System for Award Management since 2016, develops advanced DNA sequencing technologies and genotoxicity assessment solutions for federal scientific agencies.
This award reflects the FDA's continued reliance on Twinstrand's high-precision sequencing methodologies to support the agency's regulatory and scientific research functions. The Duplex Sequencing Mutagenesis Kit represents a critical tool for detecting and analyzing genetic mutations with enhanced accuracy, aligning with the FDA's mission to ensure food and drug safety through rigorous scientific analysis. Twinstrand's established track record of federal contract awards from the FDA and National Institute of Environmental Health Sciences, coupled with demonstrated technical expertise in genomic analysis, underscores the vendor's capability to deliver sophisticated research solutions to support federal scientific initiatives.
Quick answers
Who was awarded contract 75F40124P00263?
75F40124P00263 was awarded to Twinstrand Biosciences Inc. by Food and Drug Administration (Department of Health and Human Services) on June 27, 2024.
How much is contract 75F40124P00263 worth?
The government has obligated $49,988 on 75F40124P00263.
Was contract 75F40124P00263 competed?
The extent of competition for 75F40124P00263 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award